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Introduction
The Hedgehog (Hh) signaling pathway is initiated by the bind-
ing of the secreted Hh ligand to its cell surface receptor, Patched 
(Marigo et al., 1996; Stone et al., 1996). This binding event in-
activates Patched, resulting ultimately in the activation of a spe-
cific transcriptional program, which is important in embryonic 
development, adult stem cell maintenance, and carcinogenesis 
(Lum and Beachy, 2004; Ogden et al., 2004; Kalderon, 2005). 
The secreted Hh ligand is generated through a unique process. 
Hh is synthesized as a precursor that is translocated into the ER. 
The precursor undergoes cholesterol-dependent self-cleavage, 
resulting in N- and C-terminal fragments (Fig. S1 A; Lee et al., 
1994; Porter et al., 1995, 1996a,b). This process is driven by the 
intein-like activity of the C-terminal fragment in two steps (Hall 
et al., 1997). In the first step, a conserved catalytic cysteine 
in the C terminus attacks the polypeptide backbone and forms 
a thioester intermediate. In the second step, the 3-hydroxyl 
group of a cholesterol molecule displaces the C-terminal frag-
ment, generating an ester linkage with the carboxyl group of the 
N-terminal fragment. Hh processing and cholesterol modifica-
tion are critical for normal Hh signaling, and mutations in 
human Sonic Hh (Shh [HShh]) that impair processing cause 
holoprosencephaly, one of the most common congenital malfor-
mations of the brain (Traiffort et al., 2004; Maity et al., 2005; 
Roessler  et  al.,  2009).  The  cholesterol-modified  N-terminal 
fragment, further modified by palmitylation at its N terminus 
(Chamoun et al., 2001), is ultimately released from cells and is 
responsible for all the signaling effects of the Hh pathway. It is 
currently unknown where in the secretory pathway the processing 
of the Hh precursor occurs. In addition, the fate of the C-terminal 
fragment generated during the processing of the precursor   
is unclear.
Here, we demonstrate that the self-cleavage of the Hh pre-
cursor occurs in the ER, requiring the reduction of a disulfide 
bond between the catalytic cysteine and another conserved   
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DHh (MBP-DHh). The protein was expressed in Escherichia coli 
and purified as a soluble protein on an amylose affinity column. 
When incubated with high concentrations of DTT or with low 
concentrations of DTT and cholesterol, MBP-DHh underwent 
cleavage, generating an N-terminal fragment (MBP-DHh–N) 
and a C-terminal fragment (DHh-C; Fig. 1 A) as previously 
described (Porter et al., 1996b). The N-terminal fragment 
was modified with cholesterol as shown by the change in its 
electrophoretic mobility compared with the unmodified frag-
ment (Fig. 1 A, lane 4 vs. lane 3) and by the incorporation of 
3H-labeled cholesterol (Fig. 1 B).
We noticed that the precursor migrated slower on non-
reducing SDS-PAGE gels when treated with even low concentra-
tions of DTT (Fig. 1 A, lane 1 vs. lane 2). Because MBP-DHh 
contains only two cysteines, this suggests that the catalytically 
active cysteine (C258) is disulfide bonded with C400. Both cys-
teines are absolutely conserved among all Hh proteins across 
phyla. In the crystal structure of the C-terminal fragment of 
DHh (Hall et al., 1997), C258 is in close proximity to C400, 
suggesting the possibility of such a disulfide bond. Given that 
C258 needs to be reduced to act as a nucleophile in Hh process-
ing, this suggests that the disulfide-bonded species is an inactive 
precursor; the known requirement of a reducing agent for Hh 
processing in vitro (Porter et al., 1996b) could be explained by 
the need to reduce this conserved disulfide bond.
To test whether the two cysteines indeed form a disul-
fide bridge in MBP-DHh, we expressed the same protein by 
in vitro translation in reticulocyte lysate and treated it with 
cysteine in the C-terminal fragment by protein disulfide isomer-
ase (PDI). After cleavage, the C-terminal fragment is degraded 
by the ER-associated degradation (ERAD) pathway (Hirsch   
et al., 2009; Xie and Ng, 2010), providing the first example of 
an endogenous luminal ERAD substrate that is constitutively 
degraded. Degradation requires key ERAD components previ-
ously implicated in the degradation of misfolded ER proteins, 
including the ubiquitin ligase Hrd1p (Bordallo et al., 1998; 
Bays et al., 2001a), its interaction partner Sel1 (Gardner et al., 
2000; Mueller et al., 2006, 2008), and the p97 ATPase (Bays   
et al., 2001b; Ye et al., 2001; Jarosch et al., 2002; Rabinovich   
et al., 2002). Our results indicate that the generation of the 
N-terminal signaling domain of Hh in the ER is accompanied 
by the disposal of the C-terminal fragment by ERAD. We also 
show that processing-defective mutants of Hh, such as those 
causing human holoprosencephaly, are quickly degraded by the 
same ERAD pathway. Our results suggest that ERAD plays a 
critical role in birth defects caused by Hh precursor mutations.
Results
Purified Hh precursor processing requires 
a conserved noncatalytic cysteine
We first investigated the in vitro processing of the purified 
Drosophila melanogaster Hh (DHh) precursor (Lee et al., 1994; 
Porter et al., 1996a). A fusion protein was generated that con-
tains maltose-binding protein (MBP), the last 15 amino acids of 
the N-terminal fragment, and the entire C-terminal fragment of 
Figure 1.  Processing of the purified Hh precursor. (A) A fusion was generated between maltose-binding protein (MBP), the last 15 amino acids of the 
N-terminal fragment of Drosophila Hh (DHh), and the entire C-terminal fragment of DHh (MBP-DHh). The purified protein was incubated for 5 h at room 
temperature with different concentrations of DTT in the absence or presence of cholesterol (Cho). The samples were analyzed by nonreducing SDS-PAGE 
and Coomassie staining. MBP-DHh–N and DHh-C are the N- and C-terminal fragments generated by Hh processing. (B) As in A, but the reaction contained 
3H-labeled cholesterol. The samples were analyzed by reducing SDS-PAGE followed by either Coomassie staining or fluorography. (C) In vitro translated 
35S-labeled wild-type (WT) MBP-DHh or the indicated cysteine mutants were incubated with 5-kD maleimide-polyethylene glycol (Mal-PEG) as indicated, in the 
presence or absence of the reducing agent tris(2-carboxyethyl)phosphine (TCEP). The samples were analyzed by reducing SDS-PAGE and autoradiography. 
The positions of singly and doubly Mal-PEG–modified species are indicated. The singly modified species have a different mobility, depending on which 
cysteine is modified. (D) As in A, but comparing wild-type MBP-DHh with the two cysteine mutants. Molecular masses are given in kilodaltons.827 Hedgehog processing in the ER • Chen et al.
egg extracts. Radioactively labeled Xenopus Shh (XShh; Lai et al., 
1995) precursor, generated by in vitro translation in reticulocyte 
lysate, was efficiently processed when incubated with Xenopus 
egg extracts (Fig. 2 A, lanes 1–3). As in the purified system, 
both the catalytic cysteine (C199) and the noncatalytic cysteine 
(C342) were required for cleavage (Fig. 2 A, lanes 4–6 and 10–12). 
Mutation of another conserved residue shown to be important 
for cleavage in DHh (T266) also abolished processing (Fig. 2 A, 
lanes 7–9). Identical results were obtained with the corresponding 
DHh constructs, generated by in vitro translation, and incubated 
with Xenopus egg extracts (unpublished data). Consistent with 
our assumption that reduction of the disulfide bridge in the Hh 
precursor is required for processing, addition of increasing con-
centrations of oxidized glutathione (GSSG) inhibited XShh pre-
cursor cleavage (Fig. 2 B, lanes 1–12).
We next tested whether the N-terminal fragment gener-
ated in Xenopus extracts is cholesterol modified. Indeed, the 
cleavage reaction was blocked by cholesterol-sequestering de-
tergents (Fig. 2 C, lanes 4–6 and 10–12 vs. lanes 1–3 and 7–9). 
Furthermore, the N-terminal fragment generated in extracts 
partitioned into the Triton X-114 phase (Fig. 2 D, lanes 7–9) 
in contrast to the N-terminal fragment generated directly by 
in vitro translation (Fig. 2 D, lanes 1–3). The C-terminal fragment 
is also hydrophobic, as it partitioned into the detergent phase, 
whether alone or contained in the full-length protein (Fig. 2 D, 
lanes 4–6 and 7–12). Deletion of the last 93 amino acids from 
full-length XShh (XShhC) rendered the protein hydrophilic 
(Fig. 2 D, lanes 13–15). The deleted region indeed contains sev-
eral hydrophobic amino acids and might interact with choles-
terol during the intein reaction (Hall et al., 1997). This deletion 
greatly delayed, but did not completely abolish, processing of 
the precursor in Xenopus extracts (Fig. 2 E). Finally, when the 
maleimide-polyethylene glycol (Mal-PEG), a reagent that adds 
5 kD for each modified free cysteine. Whereas nonreduced 
wild-type MBP-DHh showed little modification (Fig. 1 C, lane 8), 
prior disulfide bond reduction with tris(2-carboxyethyl)phosphine 
resulted in the appearance of significant levels of singly and 
doubly Mal-PEG–modified species (Fig. 1 C, lane 9). When either 
of the two cysteines was mutated, only a singly modified protein 
was detected, even without reduction (Fig. 1 C, lanes 2 and 3 and 
lanes 5 and 6). These data indicate the formation of a disulfide 
bond between C258 and C400. As expected, mutation of the 
catalytic C258 completely blocked cleavage of MBP-DHh 
(Fig. 1 D, lanes 5–8). Interestingly, mutation of the noncatalytic 
C400 also abolished cleavage, both in the presence of high con-
centrations of DTT and low concentrations of DTT and choles-
terol (Fig. 1 C, lanes 9–12). Thus, despite the presence of a 
reduced C258, the mutant is inactive, perhaps because a di-
sulfide bond between C258 and C400 is required for the folding 
of the C terminus into a catalytically active conformation. In all 
Hh proteins, the noncatalytic cysteine is part of a conserved 
SCY sequence, and the mutation of the other two residues also 
abolishes  cleavage  of  DHh  (unpublished  data).  Collectively, 
these experiments suggest that a disulfide bridge needs to form 
between the conserved cysteines, which subsequently would 
have to be reduced for generating the thiol group required for 
intein catalysis.
Hh processing in extracts and intact  
cells also requires the conserved 
noncatalytic cysteine
To test whether the conserved noncatalytic cysteine is essential 
for the processing of a full-length vertebrate Hh precursor, we 
established a novel cell-free assay based on Xenopus laevis 
Figure 2.  Hh processing in Xenopus egg extracts. (A) The in vitro translated 
35S-labeled Xenopus Sonic Hh (XShh) wild-type (WT) precursor was incubated 
at room temperature with Xenopus egg extracts for the indicated times. Parallel experiments were performed with three point mutants. The samples were 
analyzed by SDS-PAGE and autoradiography. The graph shows the quantification of the Hh precursor. (B) As in A, but the extract was supplemented with 
the indicated concentrations of oxidized or reduced glutathione (GSSG or GSH). (A and B) n = 3 time points. (C) In vitro translated 
35S-labeled XShh fused 
at its N terminus to the maltose-binding protein (MBP-XShh) was incubated at room temperature with Xenopus egg extracts for the indicated times, in the 
absence or presence of 0.5% of either the cholesterol-sequestering detergents digitonin or cholate, or the control detergent Triton X-100 (TX-100). The samples 
were analyzed by SDS-PAGE and autoradiography. (D) In vitro translation was used to generate 
35S-labeled fusions of MBP and either the N-terminal frag-
ment of XShh (N), the C-terminal fragment of XShh (C), full-length XShh (FL), full-length XShh with a cysteine mutation in the active site (C199A), or XShh 
lacking the last 93 amino acids (C). The fusions were incubated for 1 h with Xenopus egg extracts and subjected to Triton X-114 partitioning. Aliquots 
of the input (T), of the aqueous phase (A), or of the detergent phase (D) were analyzed by SDS-PAGE and autoradiography. (E) As in A, but with an MBP 
fusion of either wild-type XShh (FL) or a mutant lacking the last 93 amino acids (C). Molecular masses are given in kilodaltons.JCB • VOLUME 192 • NUMBER 5 • 2011   828
inhibitor MG132, HShh-C accumulated, indicating that the pre-
cursor was efficiently processed and that HShh-C was normally 
degraded by the cytosolic proteasome (Fig. 3 A, lanes 5 and 6). 
Similar experiments with the processing-defective cysteine 
mutants showed that the Hh precursor is also degraded by the 
proteasome (Fig. 3, B and C, lanes 5 and 6). When HShh-C was 
expressed by itself, it was also degraded but at a slower rate 
(Fig. S1, B and C), indicating that its degradation is most effi-
cient when generated during normal processing.
Hh processing does not require vesicular 
transport out of the ER
We reasoned that the remodeling of the conserved disulfide 
bridge in Hh occurs in the ER, the site of all known disulfide 
bond formation and reduction in the secretory pathway. To test 
this assumption, we performed pulse-chase experiments after 
blocking  vesicular  transport  from  the  ER  to  the  Golgi  by 
brefeldin A (Fig. 3 E). No effect on Hh processing was observed 
at concentrations that caused the complete disappearance of the 
Golgi (Fig. S2 A) and regardless of whether or not a proteasome 
inhibitor was present (Fig. 3 E). These results strongly argue 
that both the processing of the Hh precursor and the degradation 
of HShh-C occur in the ER.
The Hh protein is a substrate for PDI
It  seemed  likely  that  remodeling  of  the  conserved  disulfide 
bridge in Hh is catalyzed by a member of the ER-localized thio-
redoxin (Trx)-like oxidoreductases, a class of enzymes gener-
ally responsible for such reactions. These enzymes contain at least 
one CXXC motif, the first cysteine of which forms a transient 
purified MBP-DHh precursor was added to Xenopus extracts, mass 
spectrometry identified cholesterol attached to the N-terminal frag-
ment (unpublished data). These data demonstrate that cholesterol 
is properly attached to Hh proteins in Xenopus egg extracts.
To test whether the conserved noncatalytic cysteine is also 
essential for the processing of the Hh precursor in intact cells, 
we stably expressed wild type or cysteine mutants of HShh 
C-terminally tagged with an HA epitope (HShh-HA) in 293T 
cells. After inhibiting protein synthesis with cycloheximide, the 
wild-type Hh precursor and the processed C-terminal fragment 
(HShh-C) were observed at early time points (Fig. 3 A). As in 
the in vitro system, no processing was observed when either the 
catalytic cysteine (C198) or the noncatalytic cysteine (C363) 
was mutated (Fig. 3, B and C, lanes 1). For both cysteine mu-
tants, the block in processing correlated with a complete ab-
sence of active Hh ligand from 293T cell supernatants as assayed 
using  Hh-responsive  NIH-3T3  cells;  in  contrast,  wild-type 
HShh-HA expressed in 293T cells resulted in a robust secretion 
of active Hh ligand (unpublished data). Consistent with the pos-
tulated role of the two conserved cysteines, a reagent that makes 
the ER more oxidizing (diamide) significantly slows down Hh 
precursor processing in mammalian cells, whereas DTT had a 
small accelerating effect as shown by pulse-chase experiments 
(Fig. 3 D and not depicted). These data support the idea that Hh 
processing requires the formation and subsequent reduction of a 
disulfide bridge between the conserved cysteines.
We noted that, after the addition of cycloheximide, both 
the Hh precursor and HShh-C disappeared in a time-dependent 
manner (Fig. 3, A–C). When the cycloheximide chase of wild-
type HShh-HA was performed in the presence of the proteasome 
Figure 3.  Processing of HShh is dependent on disulfide 
bridge formation and reduction. (A) HShh-HA was stably 
expressed in 293T cells. Protein synthesis was inhibited 
with cycloheximide (CHX), and the fate of the protein was 
followed by SDS-PAGE and immunoblotting with anti-HA 
antibodies. Immunoblotting for p97 was used as a load-
ing control. (B) As in A, but with HShh-HA containing a 
mutation in the catalytic cysteine (C198S). (C) As in A, 
but with HShh-HA containing a mutation in the conserved 
noncatalytic cysteine (C363A). (D) HA-tagged HShh was 
stably expressed in 293T cells. The cells were pulsed with 
[
35S]methionine for 3 min and chase incubated with un-
labeled methionine for the indicated times. 200 µM di-
amide or 0.5 mM DTT was added 10 min before the pulse 
and was present during the pulse and chase. The protea-
some inhibitor epoxomicin (1 µM) was present, beginning 
at 1 h before the pulse. The samples were analyzed by 
immunoprecipitation with HA antibodies followed by re-
ducing SDS-PAGE and fluorography. An equal number of 
cells were processed for each condition. (E) As in D, ex-
cept that, where indicated, 10 µM brefeldin A and 1 µM 
epoxomicin were present, which were added 1 h before 
the pulse. The samples were analyzed as in D. Molecular 
masses are given in kilodaltons.829 Hedgehog processing in the ER • Chen et al.
interactions were observed for PDI and the closely related PDIp 
protein (Fig. 4 A, first and third panels). As expected, both 
mixed disulfide adducts were sensitive to DTT treatment (Fig. 4 A, 
second and fourth panels), and no adducts were seen when one 
of the two components was omitted (Fig. S2 B). PDI and PDIp 
contain two CXXC motifs, but the reaction with Hh occurred 
overwhelmingly with the N-terminal motif. This data implies 
that the first CXXC motif of PDI is dedicated to substrate inter-
action, whereas the second CXXC motif interacts with the oxi-
dase Ero1p (Tsai and Rapoport, 2002).
PDI and PDIp reacted with both the Hh precursor and 
HShh-C (Fig. 4 A, fourth panel) as expected from the fact that 
mixed disulfide bridge with the substrate; this mixed disulfide 
intermediate can be trapped by mutating the second cysteine in 
the  CXXC  motif  (CXXA  mutants).  We  therefore  screened 
CXXA mutants of ER-localized human Trx-like proteins for the 
formation of a mixed disulfide bridge with Hh. We coexpressed 
in 293T cells FLAG-tagged CXXA mutants of nine different 
Trx-like ER proteins together with HShh-HA. Because some of 
the proteins contain more than one CXXC motif, we tested a 
total of 17 different constructs (Schulman et al., 2010). In each 
case, the formation of a mixed disulfide bridge was assayed by 
immunoprecipitation with HA or FLAG antibodies followed by 
nonreducing  SDS-PAGE  and  immunoblotting. The  strongest 
Figure 4.  PDI and PDIp are involved in the remodeling of the 
conserved disulfide bridge in HShh. (A) HShh-HA and FLAG-
tagged Trx-like ER proteins, in which one of their CXXC motifs 
was changed to CXXA, were coexpressed in 293T cells. Cell 
extracts were subjected to immunoprecipitation (IP) with HA 
or FLAG antibodies followed by SDS-PAGE and immunoblot-
ting (IB) with FLAG and HA antibodies. Where indicated, 
the  immunoprecipitated  samples  were  reduced  with  DTT 
before electrophoresis. (B) Wild-type (WT) HShh-HA or the 
processing-defective C198A mutant was coexpressed with a 
FLAG-tagged CXXA mutant of PDI (C56A) in 293T cells. The 
cells were pulse labeled with [
35S]methionine for 3 min and 
chase incubated for different time periods. The proteasome 
inhibitor epoxomicin (1 µM) was added 1 h before the pulse. 
All samples were subjected to immunoprecipitation with HA 
antibodies followed by SDS-PAGE and fluorography. Where 
indicated, the samples were reduced with DTT before electro-
phoresis. Molecular masses are given in kilodaltons.JCB • VOLUME 192 • NUMBER 5 • 2011   830
Figure 5.  HShh-C is not secreted and is degraded in the ER. (A) HShh-HA was stably expressed in 293T cells. The cells were washed and incubated for 
12 h with DME containing 0.5% fetal bovine serum. The cell pellets and equivalent amounts of culture medium were analyzed for the presence of HShh-N 
and HShh-C by immunoblotting with HShh-N antibodies and HA antibodies. Where indicated, the proteasome inhibitor epoxomicin was present during the 831 Hedgehog processing in the ER • Chen et al.
corresponds mostly to HShh-C (Fig. 5 A, immunoblots). In con-
trast to HShh-C, HShh-N was not degraded, as demonstrated by 
staining with antibodies directed against the N terminus of HShh 
(Fig. 5 C, first row). The subcellular localization of HShh-N was 
also different from that of HShh-C, with much of HShh-N local-
izing to the plasma membrane (Fig. 5 C, overlay in third row). 
The processing-defective HShh precursor mutant (HShh-C198A) 
was as unstable as HShh-C when analyzed by antibodies against 
either the N or C terminus, and it localized to the ER when stabi-
lized by proteasome inhibitors (Fig. 5 C, third and fourth panels). 
These data demonstrate that failure of processing results in the 
rapid degradation of the full-length HShh precursor in the ER.
Hh is degraded by ERAD
Next, we examined whether HShh-C generated in the ER lumen 
is  degraded  by  the  ERAD  pathway.  Luminal  glycosylated 
ERAD substrates are generally processed by glycosidases in 
their carbohydrate moiety, which is subsequently recognized by 
lectins. The substrates are then translocated into the cytosol, 
polyubiquitinated by the ubiquitin ligase Hrd1, moved into the 
cytosol by the p97 ATPase, and finally degraded by the protea-
some. Proteolysis is often preceded by deglycosylation (Wiertz 
et al., 1996). We tested which aspects of the ERAD pathway 
apply to the degradation of HShh-C.
We used RNAi to identify ERAD components required 
for the degradation of HShh-C. Depletion of the lectins impli-
cated in recognizing glycosylated ERAD substrates, OS9 or 
XTP3 (Christianson et al., 2008; Hosokawa et al., 2008, 2009; 
Bernasconi et al., 2010), caused a significant inhibition of deg-
radation (Fig. 6, A and B, quantification on the right). No fur-
ther inhibition was seen when both lectins were depleted at the 
same time (Fig. S3). Depletion of the ubiquitin ligase Hrd1 
(Bays et al., 2001a) and of its interacting partner Sel1 strongly 
stabilized HShh-C (Fig. 6, C and D). Finally, depletion of the 
ATPase p97 (Ye et al., 2001) also had a drastic inhibitory effect 
(Fig. 6 E); both the HShh precursor and HShh-C accumulated, 
indicating  that  they  both  undergo  ERAD.  The  depletion  by 
RNAi  of  other  ERAD  components,  such  as  the  Ring  finger 
ubiquitin ligases gp78 (Fang et al., 2001), TRC8 (Stagg et al., 
2009), and TEB4 (Hassink et al., 2005), as well as Derlin-1 
(Lilley and Ploegh, 2004; Ye et al., 2004), Herp (Kokame et al., 
2000; Schulze et al., 2005; Carvalho et al., 2006), BiP (Denic   
et al., 2006), and ERdj5 (Ushioda et al., 2008), had no effect on 
HShh-C degradation (Fig. S3). Addition of kifunensine or   
1-deoxymannojirimycin (Elbein, 1991) had no significant effect 
on the degradation of HShh-C (Fig. S3), indicating that mannosi-
dase I is not required for processing of the glycan on HShh-C.
The role of various ERAD components in the degradation 
of HShh was also tested by the expression of dominant-negative 
both contain the two conserved cysteines. Pulse-chase experi-
ments in the presence of a proteasome inhibitor demonstrated 
that the formation of the mixed disulfide between the Hh pre-
cursor and the CXXA mutant of PDI occurs rapidly and pre-
cedes Hh processing, including the appearance of the mixed 
disulfide adduct between HShh-C and the PDI mutant (Fig. 4 B). 
Interestingly, the mixed disulfide species can undergo the intein 
reaction with about the same kinetics as the Hh precursor itself. 
This also suggests that the noncatalytic cysteine of Hh is linked 
to PDI. Furthermore, when Hh processing was blocked by mu-
tation of the catalytic cysteine, the Hh precursor formed a mixed 
disulfide bond with the PDI mutant.
These data are consistent with a model in which PDI 
function is linked and required for Hh processing. Finally, it 
should be noted that overexpression of the PDI and PDIp mu-
tants caused the accumulation of HShh-C (Fig. 4 A, bottom), 
likely because a mixed disulfide adduct with PDI is not suscep-
tible to degradation.
HShh-C is degraded in the ER
To study the fate of HShh-C, we first considered the possibility 
that it might be secreted together with the N-terminal fragment 
(HShh-N). HShh-HA was stably expressed in 293T cells, and 
HShh-N and HShh-C were analyzed by immunoblotting with 
Hh and HA antibodies, respectively, both in cells and in equiva-
lent amounts of culture medium. Whereas HShh-N partitioned 
equally between cells and medium, HShh-C was present only in 
cells (Fig. 5 A, left). Even when HShh-C accumulated in cells 
after treatment with a proteasome inhibitor, only very small 
amounts of HShh-C were found in the medium (Fig. 5 A, right). 
These results show that HShh-C is not secreted, in contrast to 
HShh-N, the Hh ligand. Rather, the instability of HShh-C and 
its stabilization by proteasome inhibitors, even under conditions 
where vesicular transport out of the ER is blocked, suggest that 
HShh-C is degraded in the ER. Previous experiments on the se-
cretion of HShh-C can be explained by its massive overexpres-
sion and by the lack of quantification (Bumcrot et al., 1995).
To confirm that HShh-C is degraded in the ER, we tagged 
HShh with mCherry at its C terminus and visualized the protein 
by fluorescence microscopy. The protein showed the typical ER 
staining, colocalizing with calnexin (Fig. 5 B), in both 293T 
and in NIH-3T3 cells stably expressing HShh-mCherry. When 
NIH-3T3 cells stably expressing HShh-HA were treated with the 
proteasome inhibitor epoxomicin, the intensity of the staining 
increased significantly, which is consistent with HShh-C being 
degraded in the ER (Fig. 5 C, second row; and Fig. S2 C). Identi-
cal results were obtained with the proteasome inhibitors MG132 
and bortezomib (not depicted) and in 293T cells (Fig. S2 C). The 
immunofluorescent  staining  observed  under  these  conditions 
last 3 h of incubation. The graph shows the distribution of HShh-N and HShh-C between cells and medium. P, pellet. S, supernatant. Molecular masses are 
given in kilodaltons. (B) HShh was tagged with mCherry at its C terminus and stably expressed in 293T or in NIH-3T3 cells. Its localization was determined 
by fluorescence microscopy. The ER was revealed by immunostaining with rabbit antibodies against calnexin. The bottom row shows merged images. Bar, 
20 µm. (C) Wild-type HShh-HA or the processing-defective mutant HShh-C198A-HA was stably expressed in NIH-3T3 cells. Cells were immunostained with 
rat HA and rabbit HShh-N antibodies followed by goat anti–rat Alexa Fluor 488 (green) and goat anti–rabbit Alexa Fluor 594 (red) secondary antibodies. 
The cells were incubated for 3 h with or without the proteasome inhibitor epoxomicin (1 µM). The third row shows merged images of the green and red 
channels. The bottom row shows differential interference contrast (DIC) images. Bar, 50 µm.
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As with other ERAD substrates that are deglycosylated 
when arriving in the cytosol, we found that the major species 
of HShh-C accumulating in the presence of MG132 migrated 
slightly faster in SDS gels than the glycosylated fragment 
(Figs. 3, A and E; and 8 A). This band is indeed deglycosyl-
ated, as treatment of the glycosylated fragment with protein 
N-glycanase F generated a species of the same size (Fig. 8 A). 
As expected, depletion of ERAD components that block dis-
location from the ER led to the accumulation of glycosylated 
HShh-C (Fig. 6).
constructs. A catalytically inactive mutant of the ubiquitin li-
gase Hrd1, in which a cysteine in the Ring finger domain is   
altered, strongly inhibited HShh-C degradation (Fig. 7 A). 
Although overexpression of the wild-type p97 ATPase did not 
delay degradation of HShh-C, the catalytically inactive p97-QQ 
mutant was strongly inhibitory (Fig. 7 B). ERAD was similarly 
inhibited by the overexpression of catalytically inactive Ubc6e 
(Ubc6e-C91S) or by the overexpression of a GFP fusion of the 
SEL1L-interacting protein UbxD8 (UbxD8-GFP; Fig. 7 C;   
Lilley and Ploegh, 2004; Mueller et al., 2008).
Figure 6.  ERAD components required for the degrada-
tion of HShh-C. (A) Cells were depleted of the ER luminal 
lectin OS9 by siRNA, and the fate of stably expressed 
HShh-HA was followed after cycloheximide (CHX) addi-
tion. The extent of OS9 depletion (in parentheses) was 
determined by quantitative RT-PCR. Controls were treated 
with an unrelated siRNA. All samples were analyzed by 
SDS-PAGE and immunoblotting with HA antibodies. The 
right graph shows quantification of HShh-C in the experi-
ment. All samples were also analyzed by immunoblotting 
for p97 (loading control). (B) As in A, but with deple-
tion of the ER luminal lectin XTP3 by two different siRNAs.   
(C) As in A, but with depletion of the ubiquitin ligase Hrd1 
by two different siRNAs. (D) As in A, but with depletion of 
the Hrd1-interacting protein Sel1 by two different siRNAs. 
(A–D) n = 3 time points. (E) As in A, but with depletion of 
the ATPase p97 by siRNA. n = 4 time points. Molecular 
masses are given in kilodaltons.833 Hedgehog processing in the ER • Chen et al.
it requires the same components as HShh-C. Indeed, ERAD of 
the processing-defective HShh C198S mutant stably expressed 
in 293T cells was inhibited by depleting the same components, 
i.e., OS9, Hrd1, Sel1, and p97 (Fig. S5). These results show that 
the Hh precursor undergoes two competing reactions in the ER, 
cholesterol-dependent processing and degradation by an ERAD 
pathway identical to that used by HShh-C.
Discussion
The main result of the present study is that processing of the Hh 
precursor takes place in the ER. This conclusion is based on 
several observations: (a) the insensitivity of Hh processing to 
inhibition of vesicular transport out of the ER, (b) the require-
ment for disulfide bridge formation and reduction for Hh pro-
cessing,  (c)  the  involvement  of  the  ER  luminal  PDI  in  the 
disulfide remodeling of Hh, (d) the degradation of the Hh pre-
cursor and its C-terminal fragment by ERAD, and (e) micro-
scopic visualization of Hh degradation in the ER. Processing of 
the Hh precursor in the ER is somewhat unexpected given the 
relatively low concentration of cholesterol in the ER membrane. 
In fact, it was previously speculated that Hh processing might 
occur in another, cholesterol-rich compartment of the secretory 
pathway (Maity et al., 2005). How cholesterol modification can 
occur at the low cholesterol concentrations of the ER remains 
unclear, but one possibility is that an additional factor in the ER 
facilitates the reaction.
To test whether HShh-C was polyubiquitinated, we sub-
jected cell extracts expressing HShh-HA to immunoprecipi-
tation  with  HA  antibodies  followed  by  SDS-PAGE  and 
immunoblotting with ubiquitin antibodies (Fig. 8 B). Poly-
ubiquitinated HShh-HA was detected in cells treated with the 
proteasome inhibitor MG132 (Fig. 8 B, lane 2) but not in un-
treated cells even though equal amounts of HA-tagged protein 
were precipitated (Fig. 8 B, lanes 3 and 4). The specificity of the   
immunoprecipitation  was  demonstrated  by  a  control  IgG 
pull-down (Fig. S4). Polyubiquitination of HShh was depen-
dent on Hrd1, as it was inhibited by the expression of a dominant-
negative Hrd1 mutant (Fig. 8 C).
To further confirm the role of Hrd1, we tested whether it 
interacts  with  its  HShh  substrate.  Myc-tagged  wild-type  or 
dominant-negative Hrd1 were introduced into cells stably ex-
pressing HShh-HA. Cell extracts were subjected to immuno-
precipitation with HA antibodies, and precipitated proteins were 
analyzed by SDS-PAGE and immunoblotting with Myc anti-
bodies. These experiments showed that HShh-HA precipitated 
all versions of Hrd1-Myc (Fig. 8 D, lanes 6–8); less precipita-
tion was seen with wild-type Hrd1-Myc (Fig. 8 D, lane 6). An 
unrelated ER protein, Myc-tagged reticulon, did not interact 
with HShh-HA (Fig. 8 D, lane 5). Together, these experiments 
indicate that the ubiquitin ligase Hrd1 interacts with HShh sub-
strates undergoing ERAD.
Finally, because the full-length Hh precursor is also de-
graded by ERAD (Figs. 3, B and C; and 6 E), we tested whether 
Figure  7.  Dominant-negative  ERAD  compo-
nents  inhibit  HShh-C  degradation.  (A)  Cells 
stably expressing the HShh-HA precursor were 
transfected with a catalytically inactive Myc-
tagged Hrd1 (Hrd1-C291A) or with an empty 
vector.  The  fate  of  HShh-HA  was  followed 
after  addition  of  cycloheximide  (CHX),  by 
SDS-PAGE and immunoblotting for HA; immuno-
blotting for p97 served as a loading control. 
All samples were also analyzed by SDS-PAGE 
followed  by  immunoblotting  for  Myc  (Hrd1-
C291A) and for glyceraldehyde 3-phosphate 
dehydrogenase  (GAPDH;  loading  control). 
The right graph shows the quantification of the 
HShh-C in the experiment. n = 4 time points. 
(B) As in A, but with transfection of either wild-
type  p97  (p97-WT),  a  catalytically  inactive 
p97 mutant (p97-QQ), or with an empty vec-
tor. The HA blot was stripped and reprobed 
with anti-GAPDH antibodies (loading control). 
Endogenous  and  overexpressed  p97  were 
detected on the same gel by immunoblotting   
with anti-p97 antibodies. n = 3 time points.   
(C) HShh-HA was transiently expressed in 293T 
cells together with dominant-negative Ubc6e 
(Ubc6e-C91S), control vector, or UbxD8-GFP. 
Greater than 90% of the cells showed a strong 
GFP signal by live-cell fluorescence microscopy 
(not depicted). Protein synthesis was inhibited 
with cycloheximide, and the fate of HShh-HA 
was followed by SDS-PAGE and immunoblot-
ting with HA antibodies. Ponceau S staining 
of the blot is shown to demonstrate the loading 
of equal amounts of protein. Molecular masses 
are given in kilodaltons.JCB • VOLUME 192 • NUMBER 5 • 2011   834
Although the oxidation of cysteines to form disulfide bridges is 
a common protein modification in the ER, net disulfide bond re-
duction is less common. One example is provided by the reduction 
of a disulfide bond that links the A1 and A2 chains of cholera 
toxin by PDI itself; the A1 chain thus freed from the rest of the 
toxin is retrotranslocated into the cytosol (Tsai et al., 2001).
Our results show that PDI and the closely related PDIp 
protein are involved in the remodeling of the conserved disul-
fide bridge in Hh. The specificity of these enzymes is indi-
cated by the fact that seven other tested ER-localized family 
members do not interact and that only one of the two catalytic 
We show that a disulfide bond needs to form between the 
catalytic cysteine and the only other cysteine in the C-terminal 
domain, a disulfide bond that is conserved among all Hh pro-
teins. Again, this is a surprising result because, in the next step 
of Hh processing, the catalytic cysteine needs to be reduced to 
initiate cleavage of the polypeptide backbone. Why then form a 
disulfide bridge in the first place? We speculate that the Hh pre-
cursor requires a disulfide bridge for proper folding, which in 
turn is required for the autocatalytic activity of the C-terminal 
domain. Both the formation and reduction of the essential disul-
fide bridge require the activity of a member of the PDI family. 
Figure  8.  Cytoplasmic  events  preceding 
HShh-C  proteolysis.  (A)  To  test  for  deglyco-
sylation of HShh-C, HShh-HA was stably ex-
pressed in 293T cells. A cycloheximide chase 
was  performed  for  2  h  in  the  presence  or 
absence of the proteasome inhibitor MG132. 
Cell lysates were incubated in the absence or 
presence of protein N-glycanase F (PNGase F) 
as indicated. Samples were analyzed by SDS-
PAGE and immunoblotting with HA antibodies. 
Immunoblotting with p97 antibodies served as 
a loading control. (B) To test for polyubiquitina-
tion of HShh, cells stably expressing HShh-HA 
were incubated in the absence or presence of 
MG132 for 2 h. Extracts were subjected to 
immunoprecipitation (IP) with HA antibodies, 
and the proteins were analyzed by SDS-PAGE 
and  immunoblotting  (IB)  with  HA-antibodies 
(lanes 3 and 4) or ubiquitin (Ub) antibodies 
(lanes 1 and 2). Lanes 5 and 6 show blots   
of  the  extract  before  immunoprecipitation. 
(C) To test whether Hrd1 polyubiquitinates HShh, 
an experiment as in B was performed except 
that, where indicated, cells were transfected 
with  a  Myc-tagged  dominant-negative  Hrd1 
mutant (Myc-Hrd1-291A). To test for the pres-
ence of the Hrd1 mutant, the samples were 
also  analyzed  by  blotting  with  Myc  anti-
bodies. Immunoblotting for p97 served as a 
loading  control.  (D)  Cells  stably  expressing 
HShh-HA  were  transfected  with  Myc-tagged 
wild-type Hrd1 (Hrd1-WT) or catalytically in-
active Hrd1 mutants (Hrd1 C291A or Hrd1 
C291A-C307A). As a control, a Myc-tagged 
version of reticulon 4A was used. Cell extracts 
were either analyzed directly (lanes 1–4) or 
subjected to immunoprecipitation with HA anti-
bodies (lanes 5–8). All samples were analyzed 
by SDS-PAGE and immunoblotting with HA or 
Myc antibodies. Molecular masses are given 
in kilodaltons.835 Hedgehog processing in the ER • Chen et al.
proteins would be quickly degraded in the ER, and no active   
ligand would be secreted. Thus, our results suggest that ERAD 
plays a critical role in birth defects caused by Hh precursor mu-
tations. Even for the wild-type Hh precursor, ERAD might play 
a role in determining how much active ligand is generated; per-
haps, the concentration of cholesterol in the ER determines the 
balance between degradation and processing of the full-length 
precursor. Interestingly, the C-terminal fragment expressed by 
itself is also degraded but more slowly than the C-terminal frag-
ment generated through processing. Perhaps, when the frag-
ment is generated close to the ER membrane, there is a more 
efficient handover to the ERAD machinery. The signal that tar-
gets Hh to the ERAD pathway remains unclear, but it could be 
related to the hydrophobic properties of the C terminus.
Why is the posttranslational processing of Hh proteins so 
complicated? Much of the complexity of the processing mecha-
nism seems to originate from the requirement for cholesterol 
modification of the Hh ligand. Cholesterol attachment necessi-
tates the autocatalytic intein-like reaction, which in turn requires 
the C-terminal domain to be properly folded. The formation of 
a critical disulfide bond involving the catalytic cysteine ensures 
that proper folding precedes catalysis. Once the C terminus has 
done its job, however, it becomes dispensable, explaining why 
it is cleared by ERAD. Despite the progress, it remains to be 
clarified why the Hh ligand is modified by cholesterol, how 
cholesterol attachment changes its membrane association, and 
how the cholesterol-modified Hh ligand is ultimately released 
from cells.
Materials and methods
Materials
The following materials were used in this study: MG132 (Enzo Life Sci-
ences, Inc.), bortezomib (gift from A. Goldberg, Harvard Medical School, 
Boston, MA), epoxomicin (Enzo Life Sciences, Inc.), diamide (TCI Amer-
ica), rat anti-HA antibody (3F10; Roche), mouse anti-Myc antibody (9E10; 
Roche), rabbit antiubiquitin antibody (Enzo Life Sciences, Inc.), rabbit anti-
calnexin antibody (Abcam), rabbit antigigantin antibody (Abcam), rabbit 
anti-Shh (Cell Signaling Technology), protein G–agarose (GE Healthcare), 
and mouse anti-FLAG M2 agarose (Sigma-Aldrich). Stealth siRNA duplexes 
were custom synthesized by Invitrogen.
Protein purification and in vitro DHh-processing assays
A fragment of DHh comprising amino acids 244–471 was expressed in 
bacteria as an MBP fusion (MBP-DHh). The soluble MBP-DHh was purified 
on amylose beads (New England Biolabs, Inc.) according to the manufac-
turer’s instructions. Point mutations in DHh were generated using a site- 
directed mutagenesis kit (QuikChange; Agilent Technologies), confirmed 
by DNA sequencing, and expressed and purified as MBP fusions as for the 
wild-type protein. The purified proteins were concentrated to 2–5 mg/ml 
and were stored at 80°C.
Processing reactions contained 0.2–0.5 mg/ml MBP-DHh in incuba-
tion buffer (20 mM Hepes, pH 7.5, 50 mM NaCl, and 0.1% Triton X-100) 
with or without a reducing agent (DTT or glutathione) and with or without 
cholesterol (250 µM final concentration added from a stock solution in 
DMSO).  The  reactions  were  incubated  at  room  temperature  and  were 
stopped at the indicated times by the addition of SDS-PAGE sample buffer 
(with or without DTT). The samples were boiled and separated by SDS-
PAGE, and the proteins were visualized by staining with GelCode blue re-
agent (Thermo Fisher Scientific).
To assay cysteine modification by Mal-PEG, 
35S-labeled MBP-DHh 
proteins (wild type and mutants) were generated by in vitro translation in 
reticulocyte lysates and were dialyzed overnight against PBS to remove 
small molecule thiols. The proteins were incubated with or without 5 mM 
tris(2-carboxyethyl)phosphine  for  10  min  followed  by  incubation  with   
CXXC motifs of PDI and PDIp forms a mixed disulfide inter-
mediate with Hh. Whether these enzymes are involved in the 
formation of the disulfide bridge, its reduction, or both is un-
clear. However, our observation that a mixed disulfide adduct 
between Hh and PDI forms rapidly and undergoes the intein 
reaction suggests that PDI reduces the disulfide bridge in Hh 
and remains bound to the noncatalytic cysteine while the Hh 
precursor is processed. Thus, disulfide bridge reduction by 
PDI might be mechanistically coupled to Hh processing and 
attachment of cholesterol.
Consistent with our conclusion that Hh processing takes 
place in the ER, we find that the resulting C-terminal fragment 
is degraded by ERAD. The degradation of the C-terminal frag-
ment generated in the ER lumen requires several of the previ-
ously  identified  ERAD  components.  Our  data  suggest  the 
following series of events in the degradation of the C-terminal 
fragment. The process probably begins with recognition of the 
single carbohydrate chain in the C-terminal fragment, as sug-
gested by the requirement for either of the two lectins impli-
cated in ERAD, OS9 and XTP-3B. The C-terminal fragment is 
also likely recognized by Sel1, similarly to substrate recogni-
tion by the yeast homologue Hrd3p (Denic et al., 2006; Gauss   
et al., 2006). The next step in the process involves the ubiquitin 
ligase Hrd1, which forms a complex with Sel1. Once the 
substrate is polyubiquitinated on the cytosolic side of the ER 
membrane, the p97 ATPase complex moves the C-terminal 
fragment from the membrane into the cytosol. The protein is 
also deglycosylated, likely by the cytoplasmic glycanase (Hirsch 
et al., 2003). Finally, the protein is degraded by the proteasome. 
As a result of ERAD, the C-terminal fragment never leaves the 
ER and is not secreted, in contrast to the N-terminal fragment, 
the Hh ligand. Given that the C-terminal fragment is not se-
creted even when stabilized by proteasome inhibitors, it appears 
that it is actively retained in the ER, possibly by its association 
with PDI.
ERAD is normally used to degrade misfolded ER pro-
teins. In addition, there are several native proteins, such as HMG 
CoA reductase (Chin et al., 1985; Gil et al., 1985; Hampton and 
Rine, 1994), that are degraded in a regulated manner by ERAD. 
However, to our knowledge, there is only one native protein, 
Ubc6p, that is a constitutive ERAD substrate (Walter et al., 
2001). This yeast membrane protein is exposed to the cytosol 
and is continuously ubiquitinated by the Doa10p ubiquitin li-
gase (Swanson et al., 2001). The C-terminal fragment of Hh is 
the first example of a native luminal ER protein that is constitu-
tively degraded by ERAD. Whereas it is conceivable that HMG 
CoA reductase is induced to unfold by binding of cholesterol 
and that Ubc6p is not properly folded, the C-terminal fragment 
of Hh must be properly folded to allow the self-cleavage reac-
tion to happen. This hypothesis is supported by the fact that 
noncleavable versions of the full-length Hh precursor are de-
graded by ERAD at least as fast as the C-terminal fragment and 
by the same ERAD components. Apparently, the rapid degrada-
tion of the full-length Hh precursor by ERAD is competing with 
its proper processing. This can explain why HShh mutants that 
are defective in precursor processing are causing holoprosen-
cephaly, a frequent congenital brain malformation; these mutant JCB • VOLUME 192 • NUMBER 5 • 2011   836
Transfection of plasmids and siRNAs into cultured cells
Plasmids were transfected using Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s instructions. siRNA duplexes were transfected   
using a transfection reagent (TransIT-siQUEST; Mirus) at a final concentra-
tion of 50 nM siRNA according to the manufacturer’s instructions. siRNA 
transfection was performed twice, on days 1 and 3 of the experiment. On 
day 5, the cells were treated with 50 µM cycloheximide or 50 µM cyclo-
heximide plus MG132 for the period of time indicated in the figures, after 
which cells were harvested, and proteins were analyzed by SDS-PAGE and 
immunoblotting. siRNA sequences are shown in Table S1.
Quantitative RT-PCR analysis
Total RNA was extracted with TRIZOL reagent, and cDNA was synthesized 
with reverse transcriptase (ImProm-IITM; Promega). Quantitative PCR was 
performed on an ABI Prism 7900 cycler using SYBR Green PCR Master 
Mix (Applied Biosystems). The degree of siRNA knockdown was calcu-
lated relative to HPRT1 mRNA levels. The primers used to quantify mRNA 
knockdown are shown in Table S2.
Immunoblotting
Cells were lysed on ice for 20 min in TBS (10 mM Tris, pH 7.5, and 150 mM 
NaCl) supplemented with protease inhibitors and 1% Triton X-100. The lysate 
was centrifuged for 30 min at 4°C and 20,000 g. The supernatant was 
collected, mixed with SDS-PAGE sample buffer with DTT (50 mM final 
concentration), and separated by SDS-PAGE followed by immunoblot-
ting. Unless otherwise specified, p97 was used as a loading control by 
probing the p97 portion of the blot in parallel with the portion containing 
HShh and HShh-C.
Immunoprecipitation and ubiquitination of HShh-HA
293T  cells  expressing  HShh-HA  were  treated  with  or  without  50  µM 
MG132 for 2 h, and immunoprecipitation with anti-HA (3F10) antibody 
was performed as previously described (Mueller et al., 2008). The precipi-
tated proteins were separated by SDS-PAGE, and ubiquitin conjugates 
were detected by immunoblotting with antiubiquitin antibodies.
Pulse-chase assays
Pulse-chase experiments were performed as previously described (Mueller 
et al., 2006). 293T cells were detached from plates and were incubated 
in suspension in methionine- and cysteine-free DME for 1 h at 37°C. The 
cells were then labeled for 3 min at 37°C with 300 µCi/ml [
35S]methionine 
and [
35S]cysteine (
35S-Protein Express Labeling Mix; New England Nu-
clear). The cellular density during labeling was 10
7 cells/ml. The chase 
was started by adding cold methionine and cysteine at a final concentra-
tion of 5 mM and 1 mM, respectively. Aliquots of the cell suspension were 
removed at different time points, and cellular pellets were frozen. Cellular 
lysates were subjected to denaturing immunoprecipitation with HA anti-
bodies. The precipitated proteins were separated on SDS-PAGE and were 
visualized by autoradiography.
Cycloheximide chase assays
293T  cells  stably  expressing  HShh-HA  were  incubated  with  50  µg/ml   
cycloheximide in Opti-MEM (Invitrogen), in agitated suspension, at 37°C. 
At the times indicated in the figures, aliquots of the cell suspension were re-
moved and HShh-HA was detected by immunoblotting.
To determine the effect of various dominant-negative constructs on 
HShh processing, 293T cells expressing HShh-HA were transfected with 
expression constructs for Derlin1-GFP, UbxD8-GFP, or dominant-negative 
Ubc6e as previously described (Mueller et al., 2006, 2008) followed by 
cycloheximide chase 24 h after transfection.
Screening for Trx-like enzymes involved in Hh processing
We used a collection of FLAG-tagged CXXA mutants representing nine dif-
ferent human ER-localized Trx-like proteins (Schulman et al., 2010). Each 
construct was coexpressed in 293T cells with either the wild-type HShh-HA 
or the processing-defective C198A mutant. 24 h later, the cells were har-
vested and lysed, and the lysate was subjected to denaturing immuno-
precipitation  with  HA  and  FLAG  antibodies  as  previously  described 
(Schulman et al., 2010). The precipitated proteins were separated by 
SDS-PAGE under either reducing or nonreducing conditions followed by 
immunoblotting with FLAG or HA antibodies.
Analyzing Hh secretion
293T cells stably expressing HShh-HA were incubated for 12 h in DME 
containing 0.5% fetal bovine serum with or without epoxomicin added for 
the last 3 h of the incubation. The cells were harvested and lysed while the 
7 mM Mal-PEG at 5 kD (Laysan Bio, Inc.) for 30 min at room temperature. 
The reaction was terminated with 100 mM DTT, and the samples were sep-
arated by SDS-PAGE followed by autoradiography.
To determine whether MBP-DHh is modified with cholesterol, pro-
cessing reactions were performed in the presence of 0.5 µCi/µl radio-
active cholesterol (1,2,3,6,7-3H-cholesterol; 100 mCi/mmol; American 
Radiolabeled Chemicals, Inc.). The samples were separated by SDS-PAGE, 
and radioactive proteins were visualized by fluorography (Bonner and   
Laskey, 1974).
Hh processing in Xenopus egg extracts
XShh was cloned into the pCS2+ vector (Rupp et al., 1994), and radio-
active XShh was generated by in vitro translation (TNT SP6 Coupled Reticulo-
cyte Lysate System; Promega) in the presence of [
35S]methionine (New 
England Nuclear). Xenopus egg extracts were prepared as previously de-
scribed (Salic et al., 2000). A typical XShh-processing reaction contained 
1 µl of in vitro translated protein in 14 µl Xenopus egg extract supple-
mented with 100 µg/ml cycloheximide. The processing reactions were in-
cubated at room temperature, and aliquots were removed at the times 
indicated in the figures and mixed with SDS-PAGE sample buffer. The sam-
ples were boiled and separated by SDS-PAGE, and radioactive proteins 
were  visualized  by  autoradiography.  Triton  X-114–partitioning  experi-
ments were performed as previously described (Bordier, 1981) using radio-
active proteins incubated with or without Xenopus egg extract for 1 h at 
room temperature. Point mutants of XShh were generated using the Quik-
Change kit and were confirmed by DNA sequencing.
Cell culture and generation of stable cell lines
Human 293T cells were grown in DME supplemented with 10% fetal bo-
vine serum, penicillin, and streptomycin. NIH-3T3 cells were grown in DME 
with 10% bovine calf serum, penicillin, and streptomycin. To generate sta-
ble cell lines, constructs encoding full-length HShh C-terminally tagged with 
an HA epitope (HShh-HA) or fused with mCherry (HShh-mCherry) were 
cloned into the retroviral vector pLHCX (Takara Bio Inc.), and retroviruses 
were produced in 293T cells. The retroviruses were used to infect NIH-3T3 
or 293T cells, and cells stably expressing HShh-HA or HShh-Cherry were 
generated by hygromycin selection. Expression of HShh-HA or HShh-mCherry 
was confirmed by Western blotting and by immunofluorescence.
Immunofluorescence
Cultured cells were fixed in PBS with 4% formaldehyde and were permea-
bilized with TBST (10 mM Tris, pH 7.5, 150 mM NaCl, and 0.2% Triton 
X-100). Antibodies against HA (3F10, rat monoclonal; Roche), calnexin 
(rabbit polyclonal; Abcam), and gigantin (rabbit polyclonal; Abcam) were 
used at a final concentration of 0.25, 0.5, and 0.5 µg/ml, respectively.   
Alexa Fluor 594– and Alexa Fluor 488–conjugated secondary antibodies 
(Invitrogen) were used at a final concentration of 1 µg/ml. The immuno-
stained cells were imaged by epifluorescence microscopy on an inverted 
microscope (TE2000U; Nikon) equipped with a digital camera (OrcaER; 
Hamamatsu) and a 100× Plan Apochromat 1.4 NA oil objective (Nikon). 
Images were collected using Metamorph image acquisition software (Ap-
plied Precision).
293T and NIH-3T3 cells stably expressing HShh-HA were incubated 
for 3 h in the presence of control media or the proteasome inhibitors 
MG132 (10 µM), bortezomib (1 µM), or epoxomicin (1 µM). The cells 
were fixed and processed for immunofluorescence to detect the HA epi-
tope and calnexin.
DNA constructs for mammalian cell transfection
Full-length HShh, tagged at the C terminus with one copy of the HA epitope 
(HShh-HA), was cloned into pIRES2-EGFP (Takara Bio Inc.). The C-terminal 
fragment  of  HShh  (HShh-C;  amino  acids  198–462  HA  tagged  at  the   
C terminus) was cloned into pIRES2-EGFP behind a sequence encoding   
the signal sequence of CD5. Site-directed mutagenesis of HShh was per-
formed using the QuikChange kit. Wild-type and catalytically inactive p97 
(p97-WT and p97-QQ) were provided by Y. Ye (National Institutes of Health, 
Bethesda, MD); Myc-tagged wild type and the two dominant-negative mu-
tants of Hrd1 (Hrd1-WT, Hrd1-C291A, and Hrd1-C291A-C307A) were 
provided  by  E.  Wiertz  (Leiden  University,  Leiden,  Netherlands);  Myc-
tagged reticulon 4A was obtained from S.M. Strittmatter (Yale University, 
New Haven, CT); and FLAG-tagged wild type and the two inactive mutants 
of ERdj5 (ERdj5-WT, ERdj5-HQ, and ERdj5-SS) were provided by K. Nagata 
(Kyoto University, Kyoto, Japan). The Ubc6e-C91S and UbxD8-GFP ex-
pression constructs were described previously (Lilley and Ploegh, 2004; 
Mueller et al., 2008). The expression constructs for the mutant ER-localized 
Trx-like proteins were described previously (Schulman et al., 2010).837 Hedgehog processing in the ER • Chen et al.
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